- Home
- YORW vs SVRA Comparison
YORW vs SVRA Comparison
Compare YORW & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YORW
- SVRA
- Stock Information
- Founded
- YORW 1816
- SVRA 2007
- Country
- YORW United States
- SVRA United States
- Employees
- YORW N/A
- SVRA N/A
- Industry
- YORW Water Supply
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- YORW Utilities
- SVRA Health Care
- Exchange
- YORW Nasdaq
- SVRA Nasdaq
- Market Cap
- YORW 498.0M
- SVRA 505.8M
- IPO Year
- YORW N/A
- SVRA N/A
- Fundamental
- Price
- YORW $32.28
- SVRA $2.97
- Analyst Decision
- YORW
- SVRA Buy
- Analyst Count
- YORW 0
- SVRA 6
- Target Price
- YORW N/A
- SVRA $8.83
- AVG Volume (30 Days)
- YORW 65.3K
- SVRA 714.8K
- Earning Date
- YORW 05-06-2025
- SVRA 05-23-2025
- Dividend Yield
- YORW 2.73%
- SVRA N/A
- EPS Growth
- YORW N/A
- SVRA N/A
- EPS
- YORW 1.37
- SVRA N/A
- Revenue
- YORW $75,787,000.00
- SVRA N/A
- Revenue This Year
- YORW $7.50
- SVRA N/A
- Revenue Next Year
- YORW $6.33
- SVRA N/A
- P/E Ratio
- YORW $23.51
- SVRA N/A
- Revenue Growth
- YORW 3.45
- SVRA N/A
- 52 Week Low
- YORW $29.86
- SVRA $2.26
- 52 Week High
- YORW $41.96
- SVRA $5.31
- Technical
- Relative Strength Index (RSI)
- YORW 35.38
- SVRA 47.63
- Support Level
- YORW $31.96
- SVRA $2.81
- Resistance Level
- YORW $35.26
- SVRA $3.33
- Average True Range (ATR)
- YORW 0.79
- SVRA 0.22
- MACD
- YORW -0.38
- SVRA -0.04
- Stochastic Oscillator
- YORW 8.86
- SVRA 21.91
About YORW York Water Company (The)
The York Water Co is an investor-owned water utility company in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. It also owns and operates three wastewater collection systems and eleven wastewater collection and treatment systems. The company operates within its franchised territory, which covers more than 57 municipalities within four counties in south-central Pennsylvania.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.